SRPT vs. VIG
SRPT (Sarepta Therapeutics, Inc.) is a stock, while VIG (Vanguard Dividend Appreciation ETF) is Dividend fund tracking the S&P U.S. Dividend Growers Index. Over the past 10 years, SRPT returned -1.03%/yr vs 13.35%/yr for VIG. At a 0.31 correlation, their price movements are largely independent.
Performance
SRPT vs. VIG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SRPT achieves a -22.42% return, which is significantly lower than VIG's 7.01% return. Over the past 10 years, SRPT has underperformed VIG with an annualized return of -1.03%, while VIG has yielded a comparatively higher 13.35% annualized return.
SRPT
- 1D
- -3.27%
- 1M
- -0.63%
- YTD
- -22.42%
- 6M
- -25.20%
- 1Y
- -12.04%
- 3Y*
- -47.30%
- 5Y*
- -26.98%
- 10Y*
- -1.03%
VIG
- 1D
- 0.03%
- 1M
- 0.51%
- YTD
- 7.01%
- 6M
- 5.76%
- 1Y
- 17.28%
- 3Y*
- 15.86%
- 5Y*
- 10.64%
- 10Y*
- 13.35%
SRPT vs. VIG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | -22.42% | -82.30% | 26.09% | -25.58% | 43.90% | -47.18% | 32.12% | 18.24% | 96.14% | 102.84% |
VIG Vanguard Dividend Appreciation ETF | 7.01% | 14.17% | 16.99% | 14.51% | -9.80% | 23.76% | 15.43% | 29.62% | -2.08% | 22.22% |
Correlation
The correlation between SRPT and VIG is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Apr 27, 2006 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SRPT vs. VIG — Risk / Return Rank
SRPT
VIG
SRPT vs. VIG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Vanguard Dividend Appreciation ETF (VIG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRPT | VIG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.86 | ||
| Sortino ratioReturn per unit of downside risk | -2.01 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.31 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.26 | 2.19 | -2.46 |
| Martin ratioReturn relative to average drawdown | -0.58 | 8.85 | -9.43 |
Loading charts...
Drawdowns
SRPT vs. VIG - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, which is greater than VIG's maximum drawdown of -46.81%. Use the drawdown chart below to compare losses from any high point for SRPT and VIG.
Loading charts...
Drawdown Indicators
| SRPT | VIG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.17% | -46.81% | -51.36% |
Max Drawdown (1Y)Largest decline over 1 year | -45.70% | -7.91% | -37.79% |
Max Drawdown (3Y)Largest decline over 3 years | -92.72% | -14.95% | -77.77% |
Max Drawdown (5Y)Largest decline over 5 years | -92.72% | -20.39% | -72.33% |
Max Drawdown (10Y)Largest decline over 10 years | -93.33% | -31.72% | -61.61% |
Current DrawdownCurrent decline from peak | -90.66% | -1.10% | -89.56% |
Average DrawdownAverage peak-to-trough decline | -68.19% | -5.50% | -62.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.73% | 1.96% | +18.77% |
Volatility
SRPT vs. VIG - Volatility Comparison
Sarepta Therapeutics, Inc. (SRPT) has a higher volatility of 16.33% compared to Vanguard Dividend Appreciation ETF (VIG) at 2.76%. This indicates that SRPT's price experiences larger fluctuations and is considered to be riskier than VIG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SRPT | VIG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.33% | 2.76% | +13.57% |
Volatility (6M)Calculated over the trailing 6-month period | 52.61% | 7.68% | +44.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.99% | 10.09% | +83.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.86% | 14.22% | +55.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.36% | 16.04% | +54.32% |
Dividends
SRPT vs. VIG - Dividend Comparison
SRPT has not paid dividends to shareholders, while VIG's dividend yield for the trailing twelve months is around 1.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VIG Vanguard Dividend Appreciation ETF | 1.47% | 1.62% | 1.73% | 1.88% | 1.96% | 1.55% | 1.63% | 1.71% | 2.08% | 1.88% | 2.14% | 2.34% |
Frequently Asked Questions
SRPT and VIG have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SRPT has higher volatility (16.33%) compared to VIG (2.76%). In terms of maximum drawdown, SRPT dropped -98.17% vs VIG's -46.81%.
VIG currently has the higher Sharpe Ratio (1.73 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SRPT and VIG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer